Cargando…

Competing risks and cancer-specific mortality: why it matters

Detalles Bibliográficos
Autores principales:	Tan, Kay See, Eguchi, Takashi, Adusumilli, Prasad S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800900/ https://www.ncbi.nlm.nih.gov/pubmed/29484108 http://dx.doi.org/10.18632/oncotarget.23729

Ejemplares similares

Reporting net survival in populations: a sensitivity analysis in lung cancer demonstrates the differential implications of reporting relative survival and cause-specific survival
por: Tan, Kay See, et al.
Publicado: (2019)

Why we have to move beyond the idea of cultural competency
por: Wong, Sarah, et al.
Publicado: (2020)

Cell cycle progression score is a marker for five-year lung cancer-specific mortality risk in patients with resected stage I lung adenocarcinoma
por: Eguchi, Takashi, et al.
Publicado: (2016)

In Regard to: Why Racial Justice Matters in Radiation Oncology
por: Bazan, Jose G.
Publicado: (2020)

Conflict of interest and tobacco control: Why does it matter?
por: Bhatta, Dharma N., et al.
Publicado: (2022)

In Response to Comment On: Why Racial Justice Matters in Radiation Oncology
por: Gibbs, Iris C., et al.
Publicado: (2020)

The Fight for Digital Sovereignty: What It Is, and Why It Matters, Especially for the EU
por: Floridi, Luciano
Publicado: (2020)

Histologic subtyping in pathologic stage I-IIA lung adenocarcinoma provides risk-based stratification for surveillance
por: Takahashi, Yusuke, et al.
Publicado: (2018)

Comment on “Mental health: why it still matters in the midst of a pandemic”
por: Gonzalez-Diaz, Jairo M., et al.
Publicado: (2020)

The Silent Pandemic: Why COVID-19-Induced Loneliness Is No Laughing Matter
por: Bone, Matan, et al.
Publicado: (2021)

Competing risks of cystectomy – from calculator to decision
por: Dybowski, Bartosz
Publicado: (2017)

Why participation in an international clinical trial platform matters during a pandemic? Launching REMAP-CAP in Japan
por: Kamata, Kazuhiro, et al.
Publicado: (2021)

Re: Fine Particulate Matter and Total Mortality in Cancer Prevention Study Cohort Reanalysis
por: Gapstur, Susan M., et al.
Publicado: (2017)

Probiotics, prebiotics, synbiotics and naturally fermented foods: why more may be more
por: Ho, Nancy, et al.
Publicado: (2013)

Language, identity and HIV: why do we keep talking about the responsible and responsive use of language? Language matters
por: Dilmitis, Sophie, et al.
Publicado: (2012)

Response to Criticism of “Fine Particulate Matter and Total Mortality in Cancer Prevention Study Cohort Reanalysis”
por: Enstrom, James E.
Publicado: (2018)

Why zolpidem increases the risk of falls and fractures in patients with cirrhosis
por: Weersink, Rianne Antoinet, et al.
Publicado: (2022)

Reliability and validity of the resilience competency scale: Japanese short version
por: Terada, Takashi, et al.
Publicado: (2019)

Shorter antibiotic courses, but why?
por: Hudson, Warren
Publicado: (2019)

Immediate start of antiretroviral, why not?
por: Matsuda, Elaine Monteiro, et al.
Publicado: (2018)

Dystonia after Shooting Street Heroin: An Underreported Matter of Concern
por: Ghosh, Abhishek, et al.
Publicado: (2019)

Why is mental health of the geriatric population at a higher risk during the COVID-19 pandemic?
por: Mackolil, Julia, et al.
Publicado: (2020)

Why do nematomorphs leave their hosts?
por: Strona, Giovanni
Publicado: (2017)

Why we need integrative medicine
por: Roberti di Sarsina, Paolo, et al.
Publicado: (2011)

Why is medical education so expensive?
por: Walsh, Kieran
Publicado: (2014)

Why Children are Taking Up the Job?
por: Wadgave, Hanmanta V, et al.
Publicado: (2013)

Why India Needs Crashworthy Vehicles
por: Thorbole, Chandrashekhar K.
Publicado: (2016)

Why is COVID-19 rising in summer?
por: Kulkarni, Raghavendra D.
Publicado: (2021)

If Progesterone Is Blamed for Breast Cancer Development, Why Are We Still Using Tamoxifen?
por: Özkaya, Enis, et al.
Publicado: (2013)

Introducing the Western Australian Cardiovascular Research Alliance (WACRA) – Why?, Why Now? And How Can Government Help?
por: Hool, Livia C., et al.
Publicado: (2021)

Is the competency-based curriculum, evidence-based?
por: Kotur, Premanath Fakirayya
Publicado: (2022)

Intralenticular subcapsular air
por: Natesh, Sribhargava, et al.
Publicado: (2010)

Competing risk largely explains the drop in admissions for acute cardiovascular disease during the COVID-19 pandemic
por: Rodríguez-Padial, Luis, et al.
Publicado: (2020)

Continuing medical education (CME): Why the fuss?
por: Sohoni, Chandrashekhar
Publicado: (2011)

Medicinal Plants And Antioxidants: Why They Are Not Always Beneficial?
por: NASRI, Hamid, et al.
Publicado: (2014)

Taking the next step in documentation: Why and how?
por: Aggarwal, Himanshi, et al.
Publicado: (2014)

Why Do Research Ethics Committees Disagree?
por: Hotopf, Matthew
Publicado: (1995)

Leadership in nursing: why should we discuss it?
por: Cassiani, Silvia Helena de Bortoli, et al.
Publicado: (2019)

Comment: Why are females with Fabry disease affected?
por: Beck, Michael, et al.
Publicado: (2019)

Thermal Screening in COVID-19: Why Is It Commonplace?
por: Sohni, Darpan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_gdil1ennt4m5evv6f0t4g74vl9